Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Chimeric (mouse/human) |
Target | mesothelin |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 931402-35-6 |
ATC code | None |
Chemical data | |
Formula | C6394H9870N1694O2024S46 |
Mol. mass | 144.33 kDa (peptide) |
(verify) |
(what is this?)
Amatuximab is a chimeric monoclonal antibody designed for the treatment of cancer.[1]
Amatuximab was developed by Morphotek, Inc.